These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8589710)

  • 1. Round two for liver gene therapy.
    Wilson JM
    Nat Genet; 1996 Mar; 12(3):232-3. PubMed ID: 8589710
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocyte transplantation: "Only the strong survive.".
    Bezerra JA; Balistreri WF
    Hepatology; 1996 Nov; 24(5):1321-3. PubMed ID: 8903418
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
    Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M
    Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
    Overturf K; Al-Dhalimy M; Manning K; Ou CN; Finegold M; Grompe M
    Hum Gene Ther; 1998 Feb; 9(3):295-304. PubMed ID: 9508047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inborn errors of amino acid metabolism].
    Owada M
    Ryoikibetsu Shokogun Shirizu; 1995; (8):352-7. PubMed ID: 8581651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertyrosinemia].
    Endo F
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):529-31. PubMed ID: 3270860
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocyte transplantation and gene therapy.
    Raper SE
    Clin Transplant; 1995 Jun; 9(3 Pt 2):249-54. PubMed ID: 7670171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New observations on fetal liver cirrhosis associated with hereditary tyrosinemia].
    Gourdeau H; Larochelle J; Bélanger M; Bélanger L
    Union Med Can; 1985 Sep; 114(9):762-4. PubMed ID: 3840613
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation analysis for prenatal diagnosis of hereditary tyrosinaemia type 1.
    Mustonen A; Ploos van Amstel HK; Berger R; Salo MK; Viinikka L; Simola KO
    Prenat Diagn; 1997 Oct; 17(10):964-6. PubMed ID: 9358577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1995; 5(1):105. PubMed ID: 7728147
    [No Abstract]   [Full Text] [Related]  

  • 11. Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia.
    Haber BA; Chuang E; Lee W; Taub R
    Hepatology; 1996 Jul; 24(1):65-71. PubMed ID: 8707285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity.
    Jagenburg R; Landblad B; De Maré JM; Rödjer S
    J Pediatr; 1972 Jun; 80(6):994-1004. PubMed ID: 5026040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary tyrosinemia type I].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):130-3. PubMed ID: 9590006
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
    Kvittingen EA; Rootwelt H; Brandtzaeg P; Bergan A; Berger R
    J Clin Invest; 1993 Apr; 91(4):1816-21. PubMed ID: 8473520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal involvement in type I tyrosinemia].
    Cochat P; Guibaud P; Baverel G
    Arch Pediatr; 1994 Apr; 1(4):417-8. PubMed ID: 7842099
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
    Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
    Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M; Tanguay RM
    Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walking the ethical highwire: genetic screening and hereditary tyrosinemia.
    Romero R; Lavine JE
    Hepatology; 1995 Apr; 21(4):1193-5. PubMed ID: 7705795
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyrosine and its catabolites: from disease to cancer.
    Tanguay RM; Jorquera R; Poudrier J; St-Louis M
    Acta Biochim Pol; 1996; 43(1):209-16. PubMed ID: 8790725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J; Lettre F; Scriver CR; Larochelle J; Tanguay RM
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.